DDrare: Database of Drug Development for Rare Diseases

Budesonide-formoterol single inhaler (DrugBank: Formoterol, Budesonide)

3 diseases

ID	Disease name (Link within this page)	Number of trials
85	Idiopathic interstitial pneumonia	0
228	Bronchiolitis obliterans	0
299	Cystic fibrosis	1

85. Idiopathic interstitial pneumonia [ 514 clinical trials, 377 drugs, (DrugBank: 108 drugs), 97 drug target genes, 204 drug target pathways]

Searched query = "Idiopathic interstitial pneumonia", "IIPs", "Idiopathic pulmonary fibrosis", "IPF", "Usual interstitial pneumonia", "UIP", "Non-specific interstitial pneumonia", "NSIP", "Acute interstitial pneumonia", "AIP", "Diffuse alveolar damage", "DAD", "COP", "Organizing pneumonia", "OP", "Desquamative interstitial pneumonia", "DIP", "Respiratory bronchiolitis - associated interstitial lung disease", "RB-ILD", "Lymphocytic interstitial pneumonia", "LIP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 514 trial found

228. Bronchiolitis obliterans [ 92 clinical trials, 125 drugs, (DrugBank: 34 drugs), 33 drug target genes, 152 drug target pathways]

Searched query = "Bronchiolitis obliterans", "Obliterating bronchiolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 92 trial found

299. Cystic fibrosis [ 1,592 clinical trials, 1,539 drugs, (DrugBank: 255 drugs), 81 drug target genes, 162 drug target pathways]

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 1,592 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00728715 (ClinicalTrials.gov)	January 2004	31/7/2008	Efficacy of Budesonide-Formoterol in Bronchiectasis	Clinical Efficacy and Safety of Budesonide and Formoterol in the Management of Non-Cystic Fibrosis Bronchiectasis	Bronchiectasis	Drug: budesonide-formoterol single inhaler;Drug: High dose of budesonide;Drug: A;Drug: B	Hospital General de Requena	Esteve Labs (Grant)	Completed	18 Years	80 Years	Both	40	N/A	Spain